CLL treatment – a changing landscape

Join us on Monday 29th June at 11am for a webinar on chronic lymphocytic leukaemia (CLL) and its current and future treatments.

29 June 2020

This webinar will give you the opportunity to ask the experts your questions on chronic lymphocytic leukaemia (CLL) and its current and future treatments.

Date: Monday 29th June 2020

Time: 11am

Topic: CLL treatment – a changing landscape

Host: Leukaemia Care.

Guest panel:We’ll be joined by experts Professor Anna Schuh, consultant haematologist, Chair of the NCRi CLL clinical research group and Director of Molecular Diagnostics at Oxford University; Dr David Allsup, Senior Lecturer in Haematology and CLL lead at Queens Centre for Oncology and Haematology at Castle Hill Hospital, Hull; and Helen Knight, CLL Nurse Specialist at Nottingham University Hospital.

Webinar will be available online via Zoom and on Leukaemia Care’s Facebook Page.

Tune in on our Facebook page/search for Leukaemia Care on Facebook on Monday 29th June at 11am.

Please note, we will not be able to give individual medical advice. You will be directed to your own clinical team if we cannot answer your question in the webinar.

We cannot guarantee that everyone’s questions will be answered, but will try and do our best in the time frame that we have.

If you have any questions about the webinar or would like to submit a question to our panel, please email advocacy@leukaemiacare.org.uk

Juvenile Myelomonocytic Leukaemia (JMML)

Juvenile myelomonocytic leukaemia (JMML) is an excessive production of the monocyte white blood cells in the bone marrow, which infiltrate other organs including the spleen, liver, lung, and gastrointestinal tract.